Immediate KMC neurodevelopmental follow-up study.
- Registration Number
- CTRI/2019/11/021899
- Lead Sponsor
- World Health Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
All babies born alive in the participating hospitals, with birth weight between 1.0 to less then 1.8 kg, enrolled in parent study & survive the first 28 days of life are eligible for participation in this trial with their mothers. The mother-baby pair is still eligible if the mode of delivery is caesarean section, if the babies are twins or if the mother experiences some complications during labour and delivery that are expected to resolve
within 3 days.
1.Exclusion criteria (parent study)
(i) the mother is younger than 15 years of age
(ii) the mother (or her guardian in case mother is a minor aged 15-17
years) is unable or unwilling to provide consent;
(iii) the mother is unlikely to be able to provide KMC for the first 3
days after birth, e.g. she has eclampsia, shock or has undergone
major surgery;
(iv) the baby is unable to breathe spontaneously within 1 hour of
birth;
(v) multiple pregnancy: triplets or more;
(vi) the baby has a congenital malformation that interferes with the
intervention, or the intervention interferes with the required care for
the congenital malformation;
(vii) the place of residence is not a part of the defined study area (the
study area will be defined to make 28-day follow up home visit
feasible)
(viii) If for any reason the mother baby pair cannot be enrolled within 2 hours of birth of the baby.
2. Exclusion criteria (current study)
(i) The mother or guardian is unwilling to provide the consent.
(ii)The mother infant duo are unwilling to come for follow-up visits.
(iii)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method I. Developmental delay <br/ ><br>II. Cerebral palsy <br/ ><br>III. Hearing impairment <br/ ><br>IV. Vision impairment <br/ ><br>V. EpilepsyTimepoint: I. Between 24 to 30 month chronological age. <br/ ><br>II. 6,12 and 24 month <br/ ><br>III. before 3 Month <br/ ><br>IV. 12 month <br/ ><br>V. 3,6,9,12,15,18,21,24 month
- Secondary Outcome Measures
Name Time Method Feeding practicesTimepoint: 3,6,9,12,15,18,21,24 month;GrowthTimepoint: at 6,12 and 24 months of age;Home environmentTimepoint: 18 months;Maternal depressionTimepoint: 6 and 12 months of age;MortalityTimepoint: between 3 months of age and 2 years of age